ALEXANDRIA, Va., July 9 -- United States Patent no. 12,351,566, issued on July 8, was assigned to Immuneering Corp. (Cambridge, Mass.).

"MEK inhibitors and therapeutic uses thereof" was invented by Brett Matthew Hall (San Diego), Bart Lieven Decorte (Southampton, Pa.), Peter John King (San Diego), Ruben Leenders (Cambridge, Mass.), Anita Wegert (Cambridge, Mass.), Kevin Fowler (Cambridge, Mass.), Sarah Kolitz (Cambridge, Mass.), Robin Doodeman (Cambridge, Mass.), Jarno Poelakker (Cambridge, Mass.) and Rutger Henk Adriaan Folmer (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides compounds, compositions containing such compounds, and methods of designing, developin...